Nifuroxime

This classification denotes an anti-infective agent with the molecular formula C5H4N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 465N7P5U85, chemically known as 2-furancarboxaldehyde, 5-nitro-, oxime, (z)- but more generally known as nifuroxime, which bears US NIH Compound Identifier 22601. European Medicines Agency schedules Nifuroxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09272MIG. The term NIFUROXIME is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). NIFUROXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nifuroxime under HS 29321900 and SITC 51569. As of Q4 2014, NIFUROXIME remains the US FDA Preferred Term for this commodity. Nifuroxime bears US NLM identifiers UMLS ID C0028072 and NCI Concept Code C77053. SMILES: O1C(CCC1[N](=O)O)/C=N/O.